Does DENOSUMAB Cause Neoplasm progression? 406 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 406 reports of Neoplasm progression have been filed in association with DENOSUMAB (Bilprevda). This represents 0.3% of all adverse event reports for DENOSUMAB.
406
Reports of Neoplasm progression with DENOSUMAB
0.3%
of all DENOSUMAB reports
86
Deaths
92
Hospitalizations
How Dangerous Is Neoplasm progression From DENOSUMAB?
Of the 406 reports, 86 (21.2%) resulted in death, 92 (22.7%) required hospitalization, and 18 (4.4%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 406 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which DENOSUMAB Alternatives Have Lower Neoplasm progression Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE